ENZON PHARMACEUTICALS, INC. : Other Events (form 8-K)

Item 8.01 Other Events

The Board of Directors of Enzon Pharmaceuticals, Inc. (the "Company"), with respect to the fiscal year ended December 31, 2022, declared the payment of the 3% cash dividend to the holders of its 40,000 outstanding shares of Series C Non-Convertible Redeemable Preferred Stock (the "Series C Preferred Stock") in an aggregate amount of $1,274,400, or $31.86 per share of Series C Preferred Stock. The dividends will be paid on January 17, 2023, to the holders of record of the Company's Series C Preferred Stock as of January 10, 2023.

© Edgar Online, source Glimpses